JUPW - Jupiter Wellness shares rise after inking exclusive license agreement for Photocil

Jupiter Wellness (JUPW) has entered into an exclusive agreement with Applied Biology to license Photocil, a topical cream that provides relief for Psoriasis, Vitiligo and Atopic Dermatitis.Shares up nearly 7% premarket.Under the terms of the agreement, Jupiter Wellness has use of the copyrights, patents, technology, know-how, trademarks and trade-secrets of AB related to the use of Photocil.Photocil is already sold in Europe, Asia and the Middle East as Presilux and MediSun."We plan to register Photocil with the FDA and begin marketing the product immediately," CEO Glynn Wilson said.

For further details see:

Jupiter Wellness shares rise after inking exclusive license agreement for Photocil